Deep Brain Stimulation (DBS) is a treatment for Parkinson’s disease. It is a minimally invasive medical procedure which involves implanting thin copper electrodes into the cerebral cortex, which deliver electric impulses which either obstruct or alter the abnormal activity which result in Parkinson’s disease. DBS won't cure your disease, but it may help lessen your symptoms.

Market Dynamics

Approval and launch of new devices is expected to propel growth of the global deep brain stimulation devices market for Parkinson’s disease. For instance, in July 2021, the U.S. Food and Drug Administration approved Activa RC and Activa PC, deep brain stimulation devices from Medtronic Plc.

Moreover, availability of at home DBS setting is also expected to aid in growth of the global deep brain stimulation devices market for Parkinson’s disease. For instance, in June 2021, a research from University of Florida, supported by the National Institute of Nursing Research of the National Institutes of Health, demonstrated a proof of concept that could help make DBS therapy more accessible to people who are unable to travel to academic health centers or large cities where the treatment is typically available.

 Key features of the study

• This report provides in-depth analysis of the global deep brain stimulation devices market for Parkinson’s disease, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global deep brain stimulation devices market for Parkinson’s disease based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Boston Scientific Corporation, MEDTRONIC, Inc., St Jude Medical, Inc., Sapiens Neuro, and Aleva Neurotherapeutics SA
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global deep brain stimulation devices market for Parkinson’s disease report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global deep brain stimulation devices market for Parkinson’s disease

Market Segmentation

• By Product (Revenue, USD Bn, 2021-2033)
  • Single Channel
  • Dual-Channel
• By Region (Revenue, USD Bn, 2021-2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
• Key Players
  • Boston Scientific Corporation
  • MEDTRONIC, Inc.
  • St Jude Medical, Inc.
  • Sapiens Neuro
  • Aleva Neurotherapeutics SA